echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Heavy! Three years of digestion catalog publicity! These varieties are about to be cleared by local health insurance.

    Heavy! Three years of digestion catalog publicity! These varieties are about to be cleared by local health insurance.

    • Last Update: 2020-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: The use of small will be preferred out! Expert sic on the list of varieties
    today (June 8), Chongqing Municipal Health Insurance Bureau issued "on the gradual digestion of the local supplement of the list of health insurance Class B drugs" in Chongqing City, will gradually digest the local supplement of the supplement of the category B drugs. The three-year digestion principle has been governed by the author, as detailed in the table below.
    Chongqing medical insurance supplement adjustment schedule
    table finishing: Youth 10
    in accordance with the relevant national policy requirements, January 1, 2020 to formally implement the new version of the national directory
    . After the issuance of the new edition of the catalogue, in addition to special provisions, the local no longer carry out the adjustment of Class B drugs, the original addition of varieties in principle should be gradually digested within 3 years, and priority to digest the varieties included in the scope of national key monitoring. It is clearly stipulated that the provincial
    supplementary catalogue shall be
    in accordance with the principle of 442, and shall be digested within three years, according to the number of additional quantities in each province by 40%, 40% and 20%, respectively, and shall be removed from the monitoring auxiliary directory first.at present, the fastest provincial action is Anhui. On April 22, the
    Anhui Provincial Medical Insurance Bureau issued the "Anhui Province Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog Digestion Implementation Plan (Draft for Comments)"
    , clearly in the adoption of the principle of gradual adjustment of the smooth transition, within three years to complete the supplementary directory of the Ministry of Digestion. All digestive varieties will be published by the end of December 2020.action quickly return to action, Anhui all digestive varieties to wait until the end of the year to be announced, for the provinces, this 442 how to pinch, is often a shy thing. Now, Chongqing for the national provinces to supplement the catalog of varieties of adjustment, to create a model.can be seen through the above table, Chongqing adjusted the rhythm is strictly in accordance with national regulations, the first focus of monitoring out, on this basis, for the B-head of non-therapeutic drugs - health care products to adjust, the national drug quasi-word B, this category in the industry is often in a special situation, because this category of products the original number is health food, but it has the efficacy of drugs, after three clinical, obvious effect, was classified as drugs. At this time, I believe that the relevant enterprises also have nothing to say.and on the drug exchange there is no actual trading of the varieties transferred out, in line with the local band procurement "for use, quantity of one" principle, no transaction, equivalent to no actual needs in the clinic, now transferred out, of course.and according to the
    procurement from small to large sort, consider the drug habits of the insured, according to the use of small first transfer of the principle of three years of digestion adjustment,
    also basically in line with the actual clinical needs of the actual, the amount of small, can be exchanged on the fast, large amount of use, as far as possible to give a certain transition period. For real estate drugs with procurement data and other non-real estate drugs with local pharmaceutical companies producing and selling, and the proportion of sales in our city of more than 20% put in the last batch of adjustments, I believe that for all parties, this is also a reasonable demand.the original consideration of provincial medical insurance supplement, mainly from the perspective of clinical necessity, no substitutes, combined with the actual habits of local drug use, add some drugs with a certain degree of recognition, affordable, so as to expand the range of clinical and widerange patients to choose drugs. But at present, the policy of the relevant parties is very clear, that is, on the one hand, strict health insurance payment management, on the other hand clearly withdraw the local supplementary authority, based on the state's local health insurance directory management has been recovered, other provinces sooner or later will introduce transitional policies will be inevitable.Chongqing this three-year health insurance supplement directory digestion and adjustment of the initiative, no doubt for the provinces in accordance with the pace of 442 to adjust the provincial health insurance catalog opened a good start, set a model. It is believed that before long, the beginning of the adjustment of health insurance supplements around the country will take advantage of the momentum. And for the provincial health insurance catalog of medicine outlets, to seize the use of the three-year window period, can be late to adjust the early adjustment, can grasp the digestion of the stock and limited expansion of the increment of the need to grasp the speed, at the same time, but also to fully consider how to switch to OTC retail pharmacies and other opportunities, as far as possible to adjust the loss to the minimum.
    original text and annex
    in accordance with the "State Medical Insurance Bureau Of Human Resources and Social Security Department on the issuance of the National Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog Notice" (Medical Insurance Issue (2019) No. 46) provisions, for the original local drug catalogue in accordance with the provisions of the increase of Class B drugs, should be gradually digested within three years.
    combined with the actual situation of our city, determined the original local supplement of the city's medical insurance Class B drug three-year digestion principle:
    belongs to the National Medical Insurance Directory to remove varieties and no State Drug Administration drug registration approval of the drug, from January 1, 2020 will no longer be included in our city's medical insurance reimbursement (Yu medical insurance issue (2019) 80 document has been clear);
    belong to the first batch of national key monitoring reasonable Drugs of drug varieties will no longer be included in the medical insurance reimbursement of our city from June 1, 2020 (Yu Medical Insurance (2019) No. 80 has been clearly translated
    into the first year of the drug;
    documents have been included in the medical insurance catalogue, but the manufacturers have not applied for medical insurance reimbursement of drugs into the first year of digestion;
    2019 in the drug exchange no procurement data of drugs into the first year of digestion;
    real estate drugs with procurement data and local pharmaceutical companies production and sales, and the proportion of sales in our city reached 20% The above other non-real estate drugs are included in the final year of digestion,
    other drugs in accordance with the 2019 procurement of the drug exchange usage, according to the purchase volume from small to large sort, taking into account the drug habits of the insured, according to the use of small pre-emptive principle sourcing.the
    the digestive schedule is determined as: the first year of digestion of drugs, from January 1, 2021 to stop medical insurance reimbursement, the second year of digestion of drugs, from January 1, 2022 to stop medical insurance reimbursement, the third year of digestion of drugs, from July 1, 2022 to stop medical insurance reimbursement. In accordance with the above principles, the three-year list of digestive drugs prepared by the Bureau will now be published as follows:
    , publicity period
    June 8, 2020 - June 12.
    2. Receiving institutions and telephone receiving departments: Chongqing Medical Security Bureau Medical Services Management Office
    Telephone: 88979923
    Fax: 88979973
    address: Chongqing Chongqing City, Chongqing Qingsong Road 31 Chongqing Municipal Medical Security Bureau Room 505
    3, publicity requirements
    (1) according to the digestive principle, if there is a complaint to the public list, please be reflected in writing, in the form of signature.
    (ii) reflect that the person must use his real name to reflect that the situation should be true, concrete and dare to be responsible.
    (3) the receiving institution strictly keeps the persons and circumstances reflected in strict confidentiality.
    Annex:
    Year 1 Digested Drugs List

    2nd Year Digested Drugs List
    Year 3 Digested Drugs List
    Annex 1:
    1st Year Digested Drugs
    (excluding drugs that have been digested in document 2019)
    Amoxi Lin dichloroxilin (oral re-release agent type), metformin glyceme (injection), sparsac (oral chang-release agent type), methazole (slow release control release agent type), compound tiger cane anurethane (oral chang-release agent type), compound Square tramadol (oral frequently released dosage form), vitamin B12 (oral often-released agent type), gluvisin bidimensional B (oral chang-release agent type), glycine (flushing agent), ice camphor fluorine easy (patch), ammonium chlorpyrifos (including tablets), female Triols (ointments), transfer factors (injections), uric polyacid peptides (injections), Staphylococcus aureus filter preparations (injections, drug name renamed ginulyin injection), isbutite (slow release control release type), hemp-intake, An Shenjian brain fluid, antelope cold tablets, quick-acting laxative capsules, ten-taste extinction, AnShen capsule, compound ren capsule, Danyu pass pulse particles, cerebral thrombosis tablets, compound monkey head particles (capsules), Yuanhu pain relief soft capsules, anti-food Gastric tablets, loose cold live pills, Xinlikang particles, Chinese drop pills, compound three-seven capsules, injury department live blood, joint analgesic sorcerer, golden itch inglis, intestinal thai agent, silver ginseng envelope capsules, lotus capsules, return Pollen oral solution, Ganlu thirst-dissipation capsule (Chongqing Qifeng Pharmaceutical Co., Ltd.), injection cephalosporine sodium (North University Pharmaceutical Co., Ltd.), Glioquinoral disintegrating tablets (Chongqing Conkel Pharmaceutical Co., Ltd.), injection of sodium cephalosporine (Fuan Pharmaceutical Group Qing Yutang Pharmaceuticals Co., Ltd.), injection of cephalosporine Mondo sodium (Fuan Pharmaceutical Group Qing Yutang Pharmaceutical Co., Ltd.), Inhua bamcision (Chongqing Hillan Pharmaceutical Co., Ltd.), Lulu blood-replenishing particles (Taiji Group Chongqing Chinese Medicine Plant Co., Ltd.), coughing pills (Tai Chi Group Chongqing Chinese Medicine Plant Co., Ltd.), Conor Heart Capsules (Tai Chi Group Chongqing Chinese Medicine Plant Co., Ltd.), Taiji Group Chongqing Chinese Medicine Plant Co., Ltd., Tongpulse Particles (Taiji Group Chongqing Chinese Medicine Plant Co., Ltd., Tiansheng Pharmaceutical Group Co., Ltd.), Double-ginseng live blood flux particles (Chongqing SinoBio Pharmaceutical Co., Ltd.), gastrointestinal capsules (Chongqing Grillin Pharmaceutical Co., Ltd.), pediatric compound chicken (Chongqing Grillin Pharmaceutical Co., Ltd.), sugar-sugar protein-insine co., Ltd.) Lung cough tablets (Chongqing Grilling Pharmaceutical Co., Ltd.), Compound Chicken Gold Tablets (Chongqing Grillin Pharmaceutical Co., Ltd.), Compound Renititin tablets (Chongqing Corey Pharmaceuticals (Group) Co., Ltd.), Klinmycin phosphate gel (Chongqing Corey Pharmaceuticals (Group) Co., Ltd.), cephalosporine esters (Chongqing Corey Pharmaceuticals (Group) Co., Ltd.), Qumi New Emulsion (Chongqing Corey Pharmaceuticals (Group) Co., Ltd.), fine-brain injections (Chongqing Corey Pharmaceuticals(Group) Co., Ltd.) Remoscean hydrochloric acid (Chongqing Lemmy Pharmaceutical Co., Ltd.), Injection Fumetan (Chongqing Lemmy Pharmaceutical Co., Ltd.), Lianzhi anti-inflammatory tablets (Chongqing Corey South China Pharmaceutical co., Ltd.), Injection with methyl sulfonate Perfluorix (Chongqing Huasen Pharmaceutical Co., Ltd.), pediatric cough syrup (Chongqing Peace Pharmaceutical Co., Ltd.), Gui Aina-Sina capsule (Chongqing Peace Pharmaceutical Co., Ltd.), Fome.co., Ltd. Hemp cough syrup Co., Ltd. (Chongqing Oriental Pharmaceutical Co., Ltd.), semi-summer cough syrup (Chongqing Oriental Pharmaceutical Co., Ltd.), spleen and stomach shu pill (Chongqing Oriental Pharmaceutical Co., Ltd.), ten-flavored live blood pills (Chongqing Oriental Pharmaceutical Co., Ltd.), Dashan Yu Pill (Chongqing Oriental Pharmaceutical Co., Ltd.), hepatitis B positive capsule (Chongqing Oriental Pharmaceutical Co., Ltd.), anti-supping liquid (Chongqing Three Gorges Pharmaceutical Co., Ltd.), Yiqi thirst-deficinations (Tiansheng Pharmaceutical Group Co., Ltd.), plate blue blue blue particles (Tiansheng Pharmaceutical Group Co., Ltd.), riboflavin tetrabutylesteste capsules (North University International Hospital Group, Chongqing Daxin Pharmaceutical Co., Ltd.), acetyl guitar mycin particles (North International Hospital Group, Chongqing Daxin Pharmaceutical Co., Ltd.), No. 3 Snake Aurchuan Bay tablets (Chongqing Oriental Pharmaceutical Co., Ltd.), Ning Xinyi oral wisdom (Chongqing Oriental Pharmaceutical Co., Ltd.), Ning Xinyi (Chongqing Oriental Pharmaceutical Co., Ltd.), Xiantao Grass Tablets (Chongqing Oriental Pharmaceutical Co., Ltd.), Tortoise Corn (Chongqing Oriental Pharmaceutical Co., Ltd.), Hepatitis B Detox Capsules (Chongqing Oriental Pharmaceutical Co., Ltd.), Fufang Falkirk Oral Solution (Chongqing Oriental Pharmaceutical Co., Ltd.), Uber Capsules (Chongqing Doptai Pharmaceutical Co., Ltd.), multi-enzyme tablets (Chongqing Grillin Pharmaceutical Co., Ltd., Chongqing OleB.), Pediatric heopaique syrup (Sunflower Pharmaceutical Group (Chongqing) Co., Ltd.), Double Tiger Swollen Pain Spray (Sunflower Pharmaceutical Group (Chongqing) Co., Ltd.), Shilu Tong Punch (Chongqing Accompanying Pharmaceutical Co., Ltd.), Wet Pain Cream (Chongqing Accompanying Pharmaceutical Co., Ltd.), BaoXinning Capsules (Chongqing Co., Ltd.), Renanantian Anti-breathing Tablets (Tai Chi Group Chongqing Yuling Pharmaceutical Co., Ltd.), Discs (Chongqing Tiansheng Pharmaceutical Group Co., Ltd.), cold deheating particles (Chongqing Tiansheng Pharmaceutical Group Co., Ltd., Chongqing Grillin Pharmaceutical Co., Ltd.), Calconate Calvicia D2 Chewing Tablets (Southwest Pharmaceutical Co., Ltd.), Farmertin calcium chewing tablets (Southwest Pharmaceutical Co., Ltd.), glutamine particles (Chongqing Pharmaceutical Seion Pharmaceutical Co., Ltd.), Olista capsules (Chongqing Sien Pharmaceutical Co., Ltd., Chongqing Watson Pharmaceutical Co., Ltd.), Nizzin in Nitin (Chongqing Pharmaceutical Co., Ltd.), Kanazawa (Chongqing Chinese Medicine Research Hospital Pharmaceutical Factory), Women Kangbao Oral Liquid (Chongqing Qifeng Pharmaceutical Co., Ltd.), Yunzhi intracrany glum peptide oral solution (North University Pharmaceutical chongqing Daxin Pharmaceutical Co., Ltd.), Niu Huang shangqing soft gel capsule (Taiji Group Chongqing Lingling Pharmaceutical Co., Ltd.), Shenggui oral solution (Chongqing Sano Biopharmaceutical Co., Ltd.), pediatric ammonia yellow namin particles (Chongqing CorePharmaceutical (Group) Bioengineering Co., Ltd.), Wet Pain Relief Cream (Chongqing Companion Pharmaceutical Co., Ltd.), fennel joint pain cream (Chongqing Companion Pharmaceutical Co., Ltd.), pro-acid acid-to-chamine particles (Southwest Pharmaceutical Co., Ltd.), acid protein tablets (Chongqing Huafang Wulingshan Pharmaceutical Co., Ltd.), infant spleen dispersal (Sunflower Pharmaceutical Group (Chongqing) Co., Ltd.), sodium lime (Chongqing Pengcheng Industrial Co., Ltd.) Golden artemisinin detoxification particles (Tai Chi Group Chongqing Lingling Pharmaceutical Factory Co., Ltd.), compound orange infarction cough tablets (Chongqing Tiansheng Pharmaceutical Group Co., Ltd., Chongqing Grillin Pharmaceutical Co., Ltd.), methyl plaqueamine tablets (Chongqing Chinese Medicine Research Hospital Pharmaceutical Factory), compound bear bile nasal spray (Chongqing Corey Pharmaceuticals (Group) Co., Ltd.), metformin-Malayic acid Luogreketone tablets (tablets, Glawell. With compound 3D B (II), Jilin Sihuan Pharmaceutical Co., Ltd., compound cephalospora capsule (capsule, Harbin Yuheng Pharmaceutical Co., Ltd.), compound glycol injections (injections, Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Shandong Qidu Pharmaceutical Co., Ltd., Six Anhuayuan Pharmaceutical Co., Ltd., Shijiazhuang Four PharmaceuticalcoX.), s-3 fish oil in /long-chain fat injection semulity (B. Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd.), KloBuchar new.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.